Analytical Data
-
Gene name
MCP5
- Application
-
Alternative Names
MCP5；Mcp5；Scya12；C-C motif chemokine 12
-
Species
Mouse
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
287562.0
-
Expression Region
23-104aa
-
AA Sequence
GPDAVSTPVT CCYNVVKQKI HVRKLKSYRR ITSSQCPREA VIFRTILDKE ICADPKEKWV KNSINHLDKT SQTFILEPSC LG
-
Molecular Weight
9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MCP5, or Monomeric Chemokine Protein 5, has emerged as a significant focus in the field of molecular biology and immunology due to its role in mediating immune responses and its potential implications in various diseases. Understanding MCP5's structure and function is crucial as it participates in the recruitment of immune cells to sites of inflammation, thus playing a vital role in pathogen defense and tissue repair. Research on MCP5 has gained traction in light of its association with inflammatory disorders, autoimmune diseases, and cancer. Recent advances in recombinant protein technology have facilitated the production of MCP5 in a controlled environment, enabling researchers to study its properties more comprehensively. By generating recombinant MCP5, scientists can investigate its interactions with receptors, signaling pathways, and its effects on cell behavior, paving the way for the development of therapeutic strategies. The ongoing exploration of MCP5 provides insights into not only the immune system's complexities but also the potential for innovations in targeted therapies aimed at modulating immune responses, enhancing vaccine efficacy, and developing interventions for a range of health conditions. This growing body of research underscores the importance of MCP5 as a potential biomarker and therapeutic target in the ongoing quest to combat diseases linked to immune dysfunction.
